According to hematological diagnosis, patients were classified into four groups: CLL (group1, n=7), WM/LPL (group 2, n=8; WM, n=6; LPL, n=2), Other-NHL (group3, n=7; DLBCL, n=2; =2; mucosa-associated lymphoid tissue (MALT) lymphoma, n=4; Low grade B-cell lymphoma, n=1), and MGUS/MGRS (group 4, n=6) (Table 1). This evidence concerns the gene LPL and non-Hodgkin lymphoma.